期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

甲状腺癌相关肿瘤分子标志物研究进展 被引量：14

Progress in molecular markers of thyroid carcinoma
原文传递
导出
摘要 近年来，甲状腺癌的发病率处于不断上升的趋势，而且越来越多的研究者开始关注这一研究领域，学术成果逐年增多。本文将从甲状腺癌的基因诊断以及肿瘤分子标志物等方面的进展进行综述。 The incidence of thyroid carcinoma has been increasing in recent years. More and more researchers have paid attention to this field and great achievements have been made year by year. The developments on gene diagnosis and molecular markers of thyroid carcinoma are reviewed in this article.
作者 吕云福 顾文彪 谢贤和
机构地区 海南省人民医院
出处 《国际外科学杂志》 2011年第2期92-96,共5页 International Journal of Surgery
关键词 甲状腺癌 基因 诊断 生物学标志 Thyroid neoplasms Genes Diagnosis Biological markers
分类号 R736.1 [医药卫生—肿瘤]
  • 相关文献

参考文献34

  • 1Jernal A,Siegel R,Ward E,et al.Cancer statistics,2009[J].CA Cancer J Clin,2009,59(4):225-249.
  • 2Carty SE,Cooper DS,Doherty GM,et al.Consensus statement on the terminology and classification of central neck dissection for thyroid cancer[J].Thyroid,2009,19(11):1153-1158.
  • 3Yeh MW,Demircan O,Ituarte P,et al.False-negative fine-needle aspiration cytology results delay treatment and adversely affect outcome in patients with thyroid carcinoma[J].Thyroid,2004,14(3):207-215.
  • 4Hegedus L.Clinical practice:The thyroid nodule[J].N Engl J Med,2004,351(17):1764-1771.
  • 5Sherman S1.Thyroid carcinoma[J].Lancet,2003,361(9356):501-511.
  • 6Davies L,Welch HG.Increasing incidence of thyroid cancer in the United States,1973-2002[J].JAMA,2006,295(18):2164-2167.
  • 7Kumar R,Angelini S,Czene K,et al.BRAF mutations in metastatic melanoma:a possible association with clinical outcome[J].Clin Cancer Res,2003,9(9):3362-3368.
  • 8Frasca F,Nucera C,Pellegriti G,et al.BRAF (V600E) mutation and the biology of papillary thyroid cancer[J].Endocr Relat Cancer,2008,15(1):191-205.
  • 9Sapio MR,Posca D,Raggioli A,et al.Detection of RET/PTC,TRK and BRAF mutations in preoperative diagnosis of thyroid nodules with indeterminate cytological findings[J].Clin Endocrinol (Oxf),2007,66(5):678-683.
  • 10Romei C,Ciampi R,Faviana P,et al.BRAFV600E mutation,but not RET/PTC rearrangements,is correlated with a lower expression of both thyroperoxidase and sodium iodide symporter genes in papillary thyroid cancer[J].Endocr Relat Cancer,2008,15(2):511-520.

二级参考文献12

  • 1许良中,杨文涛.免疫组织化学反应结果的判断标准[J].中国癌症杂志,1996,6(4):229-231. 被引量：1380
  • 2王亚秋,华清泉.甲状腺乳头状癌中缺氧诱导因子-1α和血管内皮生长因子及血管内皮生长因子-C表达的临床意义[J].临床耳鼻咽喉头颈外科杂志,2007,21(5):204-206. 被引量：12
  • 3KRISHNAN J, KIRKIN V, STEFFEN A, et al. Differential invivo and invitro expression of vascular endothelial growth factor (VEGF)-C and VEGF-D in tumor and its relationship to lymphatic metastasis in immunocompetentrats[J]. Cancer Res, 2003, 63: 713--722.
  • 4NAKASHIMA T, KONDOH S, KITOH H, et al. Vascular endothelial growth factor-C expression in human gallbladder cancer and its relationship to lymphodemetastasis[J]. Int J Mol Med, 2003,11 : 33 -- 39.
  • 5FELLMER P T, SATO K, TANAKA R, et al. Vascular endothelial growth factor C gene expression in papillary and follicular thyroid carcinomas[J]. Surgery,1999,126:1056--1061.
  • 6GERSHENWALD J E, FIDLER I J. Targeting lymphatic metastasis [J]. Science, 2002, 296:1811 -- 1812.
  • 7MANDRIOTA S J, JUSSILA L, JELTSCH M, et al. Vascular endothelial growth factor-C mediated lymphangiogenesis promotes tumor metastasis [J]. EMBO J,2001,20:672-682.
  • 8PAPOUTSI M, SIEMEISTER G, WEINDEL K, et al. Active interaction of human A375 melanoma cells with the lymphatics in vivo[J]. Histochem Cell Biol, 2000,114:373--385.
  • 9FUNAKI H, NISHIMURA G, HARADA S, et al. Expression of vascular endothelial growth factor D is associated with lymph node metastasis in human colorectal carcinoma[J]. Oncology,2003,64:416-422.
  • 10STACKER S A, CAESAR C, BALDWIN M E, et al. VEGF-D promotes the metastatic spread of tumor cells via the lymphatics[J]. Nat Med, 2001,7 : 186 -- 191.

共引文献15

同被引文献182

引证文献14

二级引证文献91

国际外科学杂志
2011年 第2期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部